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Clinical PerspectiveWhat Is New?This study identifies gene modules that show distinct and enriched spatiotemporal expression in murine embryonic cardiomyocytes at the single‐cell level, and characterizes their relevance to functional pathway and congenital heart defects.Using new bioinformatics approaches, this study investigates the transcription factor regulatory networks regulating these modules systematically.What Are the Clinical Implications?This work can help in better understanding the regulatory targets and functional roles of many well‐known cardiac transcription factors, but also predicts additional transcription factors likely playing similar roles in embryonic cardiomyocyte development.Further studies are needed to confirm the molecular functions of the cardiac transcription factors newly implicated in embryonic heart developments and heart diseases.

Introduction {#jah34248-sec-0008}
============

Prenatal heart development is controlled by evolutionarily conserved genetic networks[1](#jah34248-bib-0001){ref-type="ref"}, [2](#jah34248-bib-0002){ref-type="ref"} consisting of well‐recognized transcription factors (TFs) (eg, *Gata4*,*Nkx2‐5*, and *Tbx5*),[3](#jah34248-bib-0003){ref-type="ref"}, [4](#jah34248-bib-0004){ref-type="ref"}, [5](#jah34248-bib-0005){ref-type="ref"} signaling pathways (eg, *WNT* and *BMP*),[6](#jah34248-bib-0006){ref-type="ref"}, [7](#jah34248-bib-0007){ref-type="ref"} and dynamic epigenetic networks that are modulated by histone modifications or DNA methylation.[8](#jah34248-bib-0008){ref-type="ref"}, [9](#jah34248-bib-0009){ref-type="ref"}, [10](#jah34248-bib-0010){ref-type="ref"} These networks ensure the precise establishment of gene expression pattern and concurrent differentiation of cardiovascular cell types in an orderly spatial and temporal manner. However, transcriptional regulatory networks involved in cardiac looping have not been fully deciphered, partially because of the lack of appropriate experimental technology for resolving cellular and developmental heterogeneity.

The introduction of single‐cell RNA‐seq technology has started to overcome this limitation. It revolutionizes the studies of gene regulation in embryonic developments by providing a systematic and high‐throughput way to profile the expression of hundreds to thousands of cells simultaneously, resulting in the discovery of new cell types, cell state transitions and functions, as well as gene markers that are associated with unique cells populations and functions.[11](#jah34248-bib-0011){ref-type="ref"}, [12](#jah34248-bib-0012){ref-type="ref"}, [13](#jah34248-bib-0013){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"}, [15](#jah34248-bib-0015){ref-type="ref"}, [16](#jah34248-bib-0016){ref-type="ref"}, [17](#jah34248-bib-0017){ref-type="ref"}, [18](#jah34248-bib-0018){ref-type="ref"} The single‐cell RNA‐seq (scRNA‐seq) data, however, have generally not been fully exploited for addressing the dynamic expression of transcription factors and their cooperative or competitive interactions, even though it is well appreciated that the expression and targets of TFs are fundamental for deciphering the cardiac genetic programs.

In this study, we took a systematic approach to analyze scRNA‐seq data to characterize gene co‐expression in differentiating cardiomyocytes at multiple anatomical locations of early cardiac developmental stages, and to investigate their regulation and maintenance by TFs. Our results indicate that the genetic programs for cardiac cell differentiation at the outflow tract--atrioventricular canal (OFT‐AVC) are extremely complex, involving many critical pathways that are regulated by a significantly large number of TFs. This finding suggests that mutations in the genes regulating OFT‐AVC development likely confer a high risk for congenital heart defects (CHD).

Methods {#jah34248-sec-0009}
=======

The authors declare that all supporting data are available within the article and its online supplemental files. The scRNA‐seq data sets were obtained from previous publications[12](#jah34248-bib-0012){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"}; data set 1 is accessible from the Gene Expression Omnibus (GEO; GSE76118), and data set 2 can be obtained from the GNomEx database (<https://b2b.hci.utah.edu/gnomex/>), with accession numbers 272R, 274R, 275R, 276R, 277R1, 279R1, 280R, 281R, and 439R.

Single Cell RNA‐Seq Data {#jah34248-sec-0010}
------------------------

The first single‐cell transcriptional data set of murine embryonic cardiac cells (data set 1) was obtained from GSE76118. The cells were captured from different anatomical locations at different time points and contained a total number of 2233 cells: cardiomyocytes (1252), epicardial cells (EPs) (40), endothelial cell (ECs) (191), mesenchymal cells (MCs) (281), and the cells with 2 or more cell‐type characters (360).[14](#jah34248-bib-0014){ref-type="ref"} The second data set (data set 2)[12](#jah34248-bib-0012){ref-type="ref"} was downloaded from the GNomEx database, with accession numbers 272R, 274R, 275R, 276R, 277R1, 279R1, 280R, 281R, and 439R. The 869 cells were mainly isolated from atrium or ventricle of murine heart cells from embryonic to postnatal days, with 484 cardiomyocytes, 146 ECs, 104 fibroblast‐enriched cells, and 135 other cells.

Data Processing and Quality Control {#jah34248-sec-0011}
-----------------------------------

Raw counts of gene expression data in data set 1 were directly obtained from the GEO, with read aligned by STAR (2.4) and expression qualified by HTSeq (0.6.1), according to the original authors.[14](#jah34248-bib-0014){ref-type="ref"} For data set 2, only fastq files were available in the GNomEx database. Thus, we used the HISAT2[19](#jah34248-bib-0019){ref-type="ref"} to align reads to the mouse genome (GRCm38.79) with its default "soft‐clip adapters," followed by SAMtool 1.4[20](#jah34248-bib-0020){ref-type="ref"} to generate alignment files and HTSeq (0.6.1)[21](#jah34248-bib-0021){ref-type="ref"} to compute read counts. To remove outlier cells (eg, doublets or abnormal cells), we qualified each cell by its total UMI and the number of expressed genes, and discarded cells not within standard normal distribution. After these quality controls, in data set 1, read counts of cells ranged from 0.55 to 3.3 million, and the numbers of expressed genes per cell were \>4000. Similarly, cells in data set 2 were retained with counts from 0.3 to 2.1 million and \>2500 expressed genes. Furthermore, genes with reads in \<50% of cells were discarded, resulting in 12 792 genes for further analysis, including 1275 TF genes, 9694 protein‐coding genes, and 1823 noncoding genes.

Cell Clustering, Dimension Reduction, and Trajectory Construction {#jah34248-sec-0012}
-----------------------------------------------------------------

The raw gene count data were processed using packages tidyr (v0.8.0),[22](#jah34248-bib-0022){ref-type="ref"} dplyr (v0.7.4),[23](#jah34248-bib-0023){ref-type="ref"} and scater (v1.6.1) packages[24](#jah34248-bib-0024){ref-type="ref"} in R. Clustering cells was carried out mainly with principal component analysis, t‐distributed stochastic neighbor embedding by the package Rtsne (0.13),[25](#jah34248-bib-0025){ref-type="ref"} and k‐means clustering by the package SC3 (1.6)[26](#jah34248-bib-0026){ref-type="ref"} in R. Ordering cells in a trajectory corresponding to a biological process was also performed by the package monocle (v2.6.1).[27](#jah34248-bib-0027){ref-type="ref"} We carried out this analysis for atrial cardiomyocytes, using data from left atrium, right atrium, and AVC of E9.5 and 10.5, ventricular cardiomyocytes, using data from left ventricular septum, right ventricular septum, left ventricle, and right ventricle of E9.5 and 10.5, and OFT cardiomyocytes, using data from OFT, proximal outflow tract, and distal outflow tract. In each case, the top 1000 most dispersed genes were used in an unsupervised manner. Furthermore, plots in this study were generated by ggplot2 (v2.2.1)[28](#jah34248-bib-0028){ref-type="ref"} while heat‐map was built by pheatmap (v1.0.8)[29](#jah34248-bib-0029){ref-type="ref"} in R.

WGCNA Co‐Expression Network {#jah34248-sec-0013}
---------------------------

Signed weighted gene co‐expression network was built from the expressed genes in data set 1, using the package weighted gene co‐expression network analysis (WGCNA) (v1.61)[30](#jah34248-bib-0030){ref-type="ref"} in R, with the scale‐free topology fit index over 0.8. More specifically, we estimated soft thresholding power and chose 10 to construct gene network using data set 1. In WGCNA, the adjacencies are used to represent gene connection strengths of gene network. In signed weighted network,$$\text{Adjacency\ score} = {(0.5 \times {(1 + \text{Cor})})}^{\land}\text{power}$$where Cor is correlation coefficient, and power is soft‐thresholding power.

From the intramodular connectivity analysis, we defined hub genes as the top connected genes (eigengene‐based connectivity, or called signed connectivity, between the gene and module eigengene \[kME\] ≥0.25).

Consensus Module Analysis {#jah34248-sec-0014}
-------------------------

The preservation of the gene modules from data set 1 was supported by consensus module analysis using the package WGCNA.[31](#jah34248-bib-0031){ref-type="ref"} The analysis built consensus modules by combining data set 1 and data set 2 and then tested whether the modules generated with data set 1 alone were preserved in the consensus modules (ie, if the genes of a given module in data set 1 were significantly enriched in any consensus module from both data sets, with *P*\<0.05). The Cytoscape[32](#jah34248-bib-0032){ref-type="ref"} and Gephi tools[33](#jah34248-bib-0033){ref-type="ref"} were used to visualize gene co‐expression networks of the modules; the node size represented connections and the length of an edge indicated the strength of the connection.

Differential Expression Analyses {#jah34248-sec-0015}
--------------------------------

The differentially expressed (DE) genes of different single‐cell clusters or subgroups were identified by the package edgeR (v3.20.1),[34](#jah34248-bib-0034){ref-type="ref"} with adjusted *P*\<0.05 as significant. Batch effects were removed when detecting differentially expressed genes, including spatial factor, temporal factor, and the condition variable.

Microarray Data and Differentially Expressed Analysis {#jah34248-sec-0016}
-----------------------------------------------------

The microarray of cardiomyopathy patients was obtained from the GEO (GSE57338),[35](#jah34248-bib-0035){ref-type="ref"} and the data for *Bmp2/4*,*Hey2*,*Nr2f2*,*Tbx3*, and *Tbx5* were also downloaded from the GEO, with accession numbers [GSE34502](GSE34502), [GSE6526](GSE6526), [GSE63759](GSE63759), [GSE73862](GSE73862), and [GSE77576](GSE77576), respectively.[36](#jah34248-bib-0036){ref-type="ref"}, [37](#jah34248-bib-0037){ref-type="ref"}, [38](#jah34248-bib-0038){ref-type="ref"}, [39](#jah34248-bib-0039){ref-type="ref"}, [40](#jah34248-bib-0040){ref-type="ref"} All the microarray data were processed using the package oligo (v1.42.0)[41](#jah34248-bib-0041){ref-type="ref"} in R, and the DE genes were detected using the package limma (v3.34.5),[42](#jah34248-bib-0042){ref-type="ref"} with adjusted *P*\<0.05.

Gene Sets, Phenotype, and Disease‐Associated Enrichment Analyses {#jah34248-sec-0017}
----------------------------------------------------------------

Pathway (GO, KEGG and Reactome)[43](#jah34248-bib-0043){ref-type="ref"}, [44](#jah34248-bib-0044){ref-type="ref"}, [45](#jah34248-bib-0045){ref-type="ref"} and gene set enrichment analyses were performed using the ToppGene suite[46](#jah34248-bib-0046){ref-type="ref"} and gene set enrichment analysis (v3.0),[47](#jah34248-bib-0047){ref-type="ref"} respectively, with FDR \<0.05 as a cutoff in David and FDR \<0.1 in gene set enrichment analysis. Phenotype and disease‐associated enrichment analyses were also carried out using the ToppGene suite, with false discovery rate (FDR) \<0.05. The enriched phenotype and disease terms (IDs) from the ToppGene were cross‐compared with the disease category information in the MGI (Mouse Genome Informatics),[48](#jah34248-bib-0048){ref-type="ref"} IMPC (International Mouse Phenotyping Consortium),[49](#jah34248-bib-0049){ref-type="ref"} and DisGeNET[50](#jah34248-bib-0050){ref-type="ref"} databases to retrieve terms related to cardiovascular systems, heart phenotypes, and cardiac diseases, resulting in 395 gene sets associated with abnormal heart phenotypes and 99 gene sets linked to cardiac diseases. The MGI: <http://www.mousemine.org/mousemine/begin.do>The IMPC: <https://www.mousephenotype.org/data/search?type=phenotype>The DisGeNET: <http://www.disgenet.org/web/DisGeNET/menu/browser?1>.

Cardiac, Literature‐Based, and Noncardiac TFs {#jah34248-sec-0018}
---------------------------------------------

To uncover potentially novel TFs involved in regulating cardiac development, we used heart phenotype‐ or disease‐associated gene sets from the MGI, IMPC, and DisGeNET databases, and literature search to separate TFs into 3 groups. "Cardiac TFs" were the TFs that have been associated (ie, annotated) within any of the heart‐phenotype gene sets from the 3 databases. The rest were then classified either as "literature‐based cardiac TFs," if there was a literature support for a function in heart development, or otherwise as "noncardiac TFs," to indicate their unknown roles in cardiac development or function.

TF‐Target Analysis {#jah34248-sec-0019}
------------------

One hundred twenty‐three TFs considered as key drivers were selected by these criteria: (1) a member of the 5 selected modules (4, 5, 6, 7, 8), (2) high expression (average cpm \>1 in the given module), and (3) a hub gene in the module. To predict the TF‐target relationship, we used the adjacency scores computed by WGCNA. Considering all the genes (n=12 792) in the signed weighted gene co‐expression network of data set 1, the top 20% adjacency values were ≥0.0017. Thus, for a TF, any gene with an adjacency ≥0.0017 was considered to be a candidate target of this TF. In TF‐target preservation analysis, this cutoff (adjacency ≥0.0017) was also applied to define TF‐targets in consensus gene co‐expression networks from both data sets 1 and 2. Because TF‐target analysis was based on the top adjacency, a TF and some of its targets might be in different modules, and our TF‐target consensus analysis included all the targets. On the other hand, to investigate the regulatory roles of TFs in the spatiotemporal modules, our enrichment analysis of a TF\'s targets discarded the targets that were in different module from the TF.

TF‐Driver Score {#jah34248-sec-0020}
---------------

To investigate and predict the effects of a TF on a given pathway, GO term, or heart phenotype gene set, we imported an approach, termed "key driver analysis,"[30](#jah34248-bib-0030){ref-type="ref"}, [51](#jah34248-bib-0051){ref-type="ref"}, [52](#jah34248-bib-0052){ref-type="ref"}, [53](#jah34248-bib-0053){ref-type="ref"}, [54](#jah34248-bib-0054){ref-type="ref"} which estimates the functions of a key driver by enrichment analysis of the driver\'s targets. The targets of 123 TFs were qualified by this approach, and we scored the results by the following formula,$$\text{Score} = \frac{T_{s}/T_{\mathit{total}}}{\text{ME}_{s}/\text{ME}_{\mathit{total}}}$$where T~s~: TF targets in the pathway; T~total~: total TF\'s targets; ME~s~: the over‐representing module genes in the pathway; ME~total~: total module genes

For each TF, we first investigated its module and the pathways, Gene Ontology (GO) terms and gene sets enriched in this module, then performed the enrichment analysis of this TF\'s targets, and finally selected the overlap between the 2 enrichment results. After determining the pathways, GO terms, and gene sets, we detected TF‐driver scores of individual TFs to explore their potential functions.

DNA Motif Enrichment Analysis {#jah34248-sec-0021}
-----------------------------

To obtain regulatory regions of mouse genes, we downloaded the murine heart E10.5 H3K27ac ChIP‐seq data from the ENCODE project[55](#jah34248-bib-0055){ref-type="ref"} (ENCSR582SPN). The peaks, corresponding to either promoters or enhances, from −50 kb to +50 kb of the transcription start site of a gene were used for motif analysis. The enrichment of TF binding motifs was performed using the AME (v4.12.0)[56](#jah34248-bib-0056){ref-type="ref"} of the MEME suite (FDR \<0.05). Motif visualization and similarity analysis were carried out using package motifStack (v1.22.0)[57](#jah34248-bib-0057){ref-type="ref"} and MotIV (v1.34.0)[58](#jah34248-bib-0058){ref-type="ref"} in R.

Animals {#jah34248-sec-0022}
-------

Wild‐type CD1 mice were obtained from Charles River Laboratories. All mouse experiments were performed according to the guideline of the National Institute of Health and the protocol approved by the Institutional Animal Care and Use Committee of Albert Einstein College of Medicine. Noontime on the day of detecting vaginal plugs was designated as E0.5.

RNA Extraction and Quantitative Polymerase Chain Reaction {#jah34248-sec-0023}
---------------------------------------------------------

The hearts were isolated from E9.5 and E10.5 embryos and separated into 3 parts: AVC, OFT, and ventricle. Tissues from 4 hearts were pooled as 1 sample and subjected to total RNAs extraction using Trizol (Life Technology) according to the manufacturer\'s manual. First‐strand cDNA was synthesized using the Superscript IV Reverse Transcriptase Kit (Life Technology). Quantitative polymerase chain reaction was performed using the Power SYBR Green PCR Master Mix (Life Technology). Gene‐specific primers were used (Table [S1](#jah34248-sup-0008){ref-type="supplementary-material"}). The relative expression level of genes was normalized to the expression level of *Gapdh* and calculated using the 2‐ΔΔCT method. Biological repeats were performed using 4 different samples. Student *t* test was used for comparison between groups and the *P* value \<0.05 was considered significant.

Results {#jah34248-sec-0024}
=======

Extraction of CM scRNA‐seq Data {#jah34248-sec-0025}
-------------------------------

The general approaches of our study are composed of construction of gene coexpression networks from scRNA‐seq data, functional enrichment analysis, and prediction of genes and pathways regulated by transcription factors (Figure [1](#jah34248-fig-0001){ref-type="fig"}). Our study started from the scRNA‐seq data that were previously obtained from mouse embryonic hearts at embryonic day (E) 8.5 to postnatal day (P) 21.[12](#jah34248-bib-0012){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"} In these 2 studies, ≈3000 single cells in total were captured for RNA‐seq from multiple dissected heart zones (eg, outflow tract and left atrium) at different developmental stages (Figure [2](#jah34248-fig-0002){ref-type="fig"}). To date, these scRNA‐seq data remain highly unique for their high gene coverage and anatomical spatial information, when compared with many subsequent scRNA‐seq data obtained by droplet‐based platforms,[59](#jah34248-bib-0059){ref-type="ref"}, [60](#jah34248-bib-0060){ref-type="ref"} and thus are especially suitable for our study. The data sets were composed of multiple cardiac cell types, including endothelial cells (EC), MC, and fibroblast‐enriched cells, and cardiomyocytes. To identify cardiomyocytes from these data, we used unsupervised clustering methods, similarly to the original reports. Principal component analysis showed that cells from each of the 2 studies ("data set 1" and "data set 2") could be segregated into 2 parts, confirmed by k‐means clustering and t‐Distributed Stochastic Neighbor Embedding analysis (Figure [S1](#jah34248-sup-0008){ref-type="supplementary-material"}A and [S1](#jah34248-sup-0008){ref-type="supplementary-material"}D). Based on the expression of known cardiac markers, we were able to identify the cardiomyocytes (expressing *Tnnc1* and *Tnni3*), EC (expressing *Cdh5* and *Tek*), and MC (expressing *Col1a1* and *Ptn*) clusters (Figure [S1](#jah34248-sup-0008){ref-type="supplementary-material"}E). Although we were unable to directly compare our cell clustering result to the original reports because cell type information was not provided in the publicly released data,[12](#jah34248-bib-0012){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"} the proportion of cells in these clusters and the expression profiles of known markers demonstrated that we had reproduced the original clustering sufficiently and separated cardiomyocytes from other cardiac cells successfully (Figure [S1](#jah34248-sup-0008){ref-type="supplementary-material"}E).

![Workflow for inferring transcription factor (TF)‐target regulatory network. **A**, Overview of our approach for identifying and characterizing gene co‐expression patterns in cardiomyocytes. The t‐distributed stochastic neighbor embedding (tSNE) map indicates the gene expression similarity among cardiomyocytes, while the weighted gene co‐expression network analysis (WGCNA) heatmap shows co‐expression patterns of genes across cardiomyocytes in different spatial or temporal subgroups. The plot for the predicted TF targets display a TF (dash circle) and its targets that are in the same gene module, with colors for different types of module genes. **B**, Schematic illustration of function analysis for TF targets. Left panel shows that the potential functional roles of a TF could be predicted by enrichment analysis of its targets, with the dashed box highlighting targets of a TF (red). Right panel shows the enrichment results from the analysis of targets for less‐studied TFs, with colors for TF‐driver scores that quantify the potential regulatory effects of a TF on individual gene sets. See [Methods](#jah34248-sec-0009){ref-type="sec"} for details. A indicates atrium; AVC, atrioventricular canal; DO, distal outflow tract; LA, left atrium; LS, left ventricular septum; LV, left ventricle; OFT, outflow tract; PO, proximal outflow tract; RA, right atrium; RS, right ventricular septum; RV, right ventricle.](JAH3-8-e012941-g001){#jah34248-fig-0001}

![Identification of gene expression patterns for cardiomyocytes at different anatomical location or developmental stage. **A**, The t‐SNE map of the cardiomyocytes in data set 1. **B**, Ten gene modules generated by WGCNA (weighted gene co‐expression network analysis). Columns of the heatmap represent individual cardiomyocyte cells, grouped by their anatomical and developmental stage origins, while each row is a gene module, with heat‐map colors indicating the relative expression of its eigengene. **C**, Module eigengene patterns at t‐SNE map of cardiomyocyte cells, with colors for module eigengene expressions. AVC indicates atrioventricular canal; OFT, outflow tract; t‐SNE, t‐distributed stochastic neighbor embedding.](JAH3-8-e012941-g002){#jah34248-fig-0002}

Spatiotemporal‐Specific Transcriptional Heterogeneity of Cardiomyocytes {#jah34248-sec-0026}
-----------------------------------------------------------------------

As cardiomyocytes were captured at different developmental stages and anatomical locations, we first studied the contributions of these 2 factors (time and location) and additional technical factors to gene expression variation (see [Methods](#jah34248-sec-0009){ref-type="sec"}). We found that the number of expressed genes in individual cardiomyocytes and anatomical origin explained the most expression variations, followed by developmental stage, but sequencing depth ("counts") was not a main factor (Figure [S2](#jah34248-sup-0008){ref-type="supplementary-material"}A). Thus, we considered that the gene expression heterogeneity across cardiomyocyte groups mostly reflected biological difference, consistent with the original reports.[12](#jah34248-bib-0012){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"} We should point out that in this study we did not directly integrate the 2 data sets but analyzed them together, as they were generated with 2 quite different strategies and thus could have batch effects. Data set 1 served as the primary data source for our analyses and conclusions, while data set 2 was used mostly to confirm our findings of gene co‐expression among cardiomyocytes at different anatomical locations or developmental stages.

Accounting for developmental stages and anatomical locations, the cardiomyocytes in data set 1 could be approximately classified into 4 main clusters (Figure [2](#jah34248-fig-0002){ref-type="fig"}A). Excluding outliers (cells in gray in Figure [2](#jah34248-fig-0002){ref-type="fig"}A), E8.5 cardiomyocytes appeared as 1 cluster, while the cardiomyocytes at E9.5 and E10.5 could be segregated into 3 clusters based on anatomical locations: "atrial cluster" (left atrium, right atrium, and AVC), "ventricular cluster" (LV, left ventricular septum, RV, right ventricular septum), and "outflow tract cluster" (E9.5 outflow tract and distal outflow tract) (Figure [2](#jah34248-fig-0002){ref-type="fig"}A and Figure [S2](#jah34248-sup-0008){ref-type="supplementary-material"}B). We also noticed that E10.5 cardiomyocytes from proximal outflow tract showed higher gene expression similarity to RV cardiomyocytes than E9.5 OFT or E10.5 distal outflow tract cardiomyocytes. In summary, the E8.5 to E10.5 cardiomyocytes can be separated mainly by their temporal (developmental stages) and spatial (anatomical locations) origins that reflect their developmental trajectories.

We next carried out signed WGCNA (see [Methods](#jah34248-sec-0009){ref-type="sec"}) to define co‐expressed gene modules, and studied their relationship to the 4 main cardiomyocytes clusters. The analysis resulted in 10 gene modules from the 12 792 genes expressed in both data sets (Figure [2](#jah34248-fig-0002){ref-type="fig"}B), with the module sizes ranging from 63 to 7524. Interestingly, the 10 modules contained different proportions of noncoding genes and TFs (Figure [S2](#jah34248-sup-0008){ref-type="supplementary-material"}C and Table [S2](#jah34248-sup-0003){ref-type="supplementary-material"}), suggesting potentially different degrees of regulation complexity. A comparison of the WGCNA result with the t‐distributed stochastic neighbor embedding cell clustering map and cell sample origins revealed that some of the module eigengenes, representing the first principal component of gene expression profiles in individual modules, displayed a strong correlation with specific cardiomyocytes clusters or groups (Figure [2](#jah34248-fig-0002){ref-type="fig"}B and [2](#jah34248-fig-0002){ref-type="fig"}C, Figure [S2](#jah34248-sup-0008){ref-type="supplementary-material"}B). Therefore, our work unveiled cardiomyocytes from different temporal or spatial origins, for which we identified genes with highly similar expression patterns. To address the robustness of the gene modules, we performed consensus module analysis by incorporating the scRNA‐seq data of cardiomyocytes from E9.5 to 18.5 in data set 2[12](#jah34248-bib-0012){ref-type="ref"} (see [Methods](#jah34248-sec-0009){ref-type="sec"}). The results confirmed that all gene modules were reproducible (ie, "preserved," Figure [3](#jah34248-fig-0003){ref-type="fig"} and Figure [S3](#jah34248-sup-0008){ref-type="supplementary-material"}), indicating that most modular genes have similar co‐expression correlation in the 2 data sets, and the gene expression pattern is most likely a result of gene programs regulating embryonic cardiomyocytes development.

![Preservation analysis of the weighted gene co‐expression network analysis modules. The dot size indicates the odds ratio and the *y*‐axis shows the significance. The red line indicates the threshold (*P*\<0.05) for significant preservation.](JAH3-8-e012941-g003){#jah34248-fig-0003}

Functional Analysis of the WGCNA Module Genes {#jah34248-sec-0027}
---------------------------------------------

We performed GO and pathway analyses to characterize the enriched functions of module genes (see [Methods](#jah34248-sec-0009){ref-type="sec"}), focusing on the spatial and temporal modules (Figure [4](#jah34248-fig-0004){ref-type="fig"}A and Table [S3](#jah34248-sup-0004){ref-type="supplementary-material"}). In the temporal modules, the genes of module 6 (E8.5 cardiomyocytes module) were enriched for function terms in regulation of cell differentiation, positive regulation of gene expression, and response to endogenous stimulus, including module genes *Gsk3b*,*Notch2*, and *St13* (Figure [4](#jah34248-fig-0004){ref-type="fig"}B), indicating that this gene module is mainly involved in cell differentiation, concordant with the proliferation of early‐stage cardiomyocytes.[61](#jah34248-bib-0061){ref-type="ref"}, [62](#jah34248-bib-0062){ref-type="ref"} The module 5 (E10.5 cardiomyocytes module) genes were enriched in oxidative phosphorylation, electron transport chain, and cardiac muscle contraction signaling known to be highly active in late‐stage cardiomyocytes.[63](#jah34248-bib-0063){ref-type="ref"} Not only did this module include troponin and ryanodine receptor genes, but also it contained a number of important electron transport genes from mitochondrial genome, such as *mt‐Co2*,*mt‐Co3*, and *mt‐Atp6* (Figure [4](#jah34248-fig-0004){ref-type="fig"}B), indicating distinct enhancement of mitochondrial ATP synthesis along with cardiomyocyte development (Table [S3](#jah34248-sup-0004){ref-type="supplementary-material"}).

![Enrichment analysis of genes in selected modules. **A**, The top 7 representative enriched Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in the 5 selected modules. The networks in the middle illustrate the co‐expression networks of genes in these modules, with the nodes representing genes and node sizes proportion to the numbers of co‐expressed genes. Functional terms and pathways for individual modules are depicted by matching colors. **B**, Expression patterns of hub genes in 5 selected modules. **C**, Enriched phenotype‐ and disease‐associated gene sets in the modules. The gene sets (columns) associated with heart phenotypes and diseases were enriched in the gene modules. The colors in the heat‐map show statistical significance of enrichments, and some representative gene sets are labeled at the bottom. ALK indicates Anaplastic lymphoma kinase; EDS, Ehlers‐Danlos syndrome; EDSP, Ehlers‐Danlos syndrome progeroid; JDSSDHD, joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects; SEMDJL, Spondyloepimetaphyseal dysplasia with joint laxity; NGF, nerve growth factor.](JAH3-8-e012941-g004){#jah34248-fig-0004}

In contrast, the OFT‐AVC module genes (from spatial module 4) were enriched for terms important in cardiac morphogenesis, tube development, cardiovascular system development, and cellular response to growth factor stimulus. These processes have been reported to activate OFT remodeling.[62](#jah34248-bib-0062){ref-type="ref"} Interestingly, transforming growth factor β (TGFβ), bone morphogenetic protein (BMP), and SMAD pathways, with their key regulators *Bmp2/4*,*Tgfb2*,*Id1/2/3*, and *Smad 6/7* (Figure [4](#jah34248-fig-0004){ref-type="fig"}B), were enriched in module 4; they are known for roles in OFT and/or AVC development and morphogenesis.[7](#jah34248-bib-0007){ref-type="ref"}, [62](#jah34248-bib-0062){ref-type="ref"}, [64](#jah34248-bib-0064){ref-type="ref"} Interestingly, our analysis showed that genes in additional signaling pathways, such as nerve growth factor, vascular endothelial growth factor, SCF (stem cell factor)‐KIT, platelet‐derived growth factor, mitogen‐activated protein kinase, AKT, insulin‐like growth factor, interleukins, leptin, and insulin, were also significantly overrepresented in this module. These results indicate that OFT‐AVC formation and remodeling are tightly regulated by a complex network of signaling pathways in response to both external growth factors and endogenous stimuluses. Our finding is consistent with previous studies of protein and gene networks critical for heart development,[65](#jah34248-bib-0065){ref-type="ref"}, [66](#jah34248-bib-0066){ref-type="ref"} but our analysis also uncovered additional novel pathways that were not described before, such as DAP12 (also called KARAP) signaling (Figure [4](#jah34248-fig-0004){ref-type="fig"}A and Table [S3](#jah34248-sup-0004){ref-type="supplementary-material"}). For module 7 (ventricular cardiomyocytes module), function analysis identified enriched terms in muscle structure development, cardiovascular system development, and regulation of cardiac contraction. The module 8 genes, actively expressed in atrial cardiomyocytes, exhibited significant enrichments in cell movement, response to endogenous stimulus, and ion signaling. Additionally, some well‐known cardiac genes involved in cardiac contraction were members of these 2 modules, such as cardiac myosin *Myl2* and *Myh7* in module 7, and *Myh6* and tropomyosin *Tpm2* in module 8 (Figure [4](#jah34248-fig-0004){ref-type="fig"}B and Table [S2](#jah34248-sup-0003){ref-type="supplementary-material"}). All these results emphasize that our unbiased and systematic function analysis of spatiotemporal module genes uncovered both known and potentially novel signaling pathways in cardiomyocytes at different anatomical locations or heart looping stages, thus providing molecular profiles for the diverse developmental processes and cellular functions in embryonic cardiomyocytes.

Modular Enrichment of Cardiac Phenotype‐ and Disease‐Associated Genes {#jah34248-sec-0028}
---------------------------------------------------------------------

We next addressed how genes associated with different heart phenotypes or diseases were distributed in these gene modules, using the ToppGene and Fisher exact test (see [Methods](#jah34248-sec-0009){ref-type="sec"}). Surprisingly, the results indicated that even though modules 1, 2, and 3 contained \>80% of the expressed genes, phenotype or disease marker genes were most significantly enriched in modules 4, 5, 7, and 9 (adjusted *P*\<0.05) (Figure [4](#jah34248-fig-0004){ref-type="fig"}C and Table [S4](#jah34248-sup-0005){ref-type="supplementary-material"}). These results support the value of our demarcation of gene modules, as it separated correctly the developmental and disease‐relevant gene modules from others. In addition, this analysis uncovered the genetic relationship between developmental process and heart abnormalities, thus highlighting the developmental bases of some heart diseases.

Prediction of Targets for Spatiotemporal Transcription Factors {#jah34248-sec-0029}
--------------------------------------------------------------

After studying the spatiotemporal expression of genes by co‐expression networks and functional enrichment analysis, we set out to address the primary goal of the current study: how the spatiotemporal expression and networks were regulated and maintained. In total, 186 TFs were present in the 5 selected modules (temporal‐ or spatial‐specific modules). One hundred three of them were highly expressed in module 4 (OFT‐AVC module), including T‐boxes TFs (*Tbx2*,*Tbx3*, and *Tbx20*), Kruppel‐like TFs (*Klf3*,*Klf4*,*Klf6*, and *Klf7*), Gata family (*Gata2*,*Gata3*,*Gata5*, and *Gata6*) and Id family (*Id1*,*Id2* and *Id3*), as well as a large number of TFs whose functions in cardiac development remain unclear, like *Bach2*,*Etv5*, and *Skil*. We also found that 12 TFs were in the E10.5 module (module 5), 27 TFs were active expression in the E8.5 module (module 6), 20 and 24 TFs in ventricular module (module 7) or atrial module (module 8), respectively, including well‐studied cardiac genes *Hey2*,*Irx4*,*Sox5*, and *Tbx5*. The expression patterns of some representative TFs in these modules are shown in Figure [5](#jah34248-fig-0005){ref-type="fig"}A.

![Spatiotemporally expressed TFs and their potential targeted genes. **A**, Expression patterns of 9 representative TFs (transcription factors) in the selected modules. **B**, The enriched motifs in the predicted targets of the representative TFs, with TF names and q‐values at the top. **C**, Preservation of TF‐targets. Bubbles in the plot represent different TFs, with colors for the significance of preservation and sizes for odds ratios of target overlap. **D**, Mean expression and eigengene‐based connectivity of the candidate TF drivers (n=123). In plot, *x*‐axis represents the correlations between TFs' expression profiles and their corresponding module eigengenes, while *y*‐axis represents the average expression values for TFs. TFs indicates transcription factors.](JAH3-8-e012941-g005){#jah34248-fig-0005}

To predict the targets for individual TFs, we used the adjacency scores computed by WGCNA for quantifying the co‐expression strengths between genes, whereas we considered a gene as a TF\'s target if their pairwise adjacency score was at the top 20% of all adjacency scores in the full co‐expression network (see [Methods](#jah34248-sec-0009){ref-type="sec"}). As such, TFs in the same module could have a very different list of targets. To support our TF‐target prediction, we first performed motif analysis for 82 TFs that have known DNA binding motifs. The result showed that for ≈80% of them, the corresponding motifs (or the motifs for the same TF family) were significantly enriched in the regulatory regions (defined by enriched H3K27ac modification, see [Methods](#jah34248-sec-0009){ref-type="sec"}) of their targets (Figure [5](#jah34248-fig-0005){ref-type="fig"}B and Table [S5](#jah34248-sup-0006){ref-type="supplementary-material"}). Next, we re‐analyzed several published microarray gene expression data sets, in which the expression of *Hey2*,*Nr2f2*,*Tbx3*, and *Tbx5* in hearts was disrupted.[36](#jah34248-bib-0036){ref-type="ref"}, [37](#jah34248-bib-0037){ref-type="ref"}, [38](#jah34248-bib-0038){ref-type="ref"}, [39](#jah34248-bib-0039){ref-type="ref"}, [40](#jah34248-bib-0040){ref-type="ref"} We asked whether the differentially expressed genes upon knockdown or knockout of these TFs were correlated with the targets predicted by our method, using the χ^2^ test. The results showed significant correlations, *Hey2* (*P*\<2.2e‐16), *Nr2f2* (*P*=1.246e‐06), *Tbx3* (*P*=0.00056), and *Tbx5* (*P*=1.457e‐05). Lastly, we repeated the TF‐target prediction using the consensus gene network built by both scRNA‐seq data sets and found that for 184 of the 186 TFs the predicted targets were reproducible (*P*\<0.05) (Figure [5](#jah34248-fig-0005){ref-type="fig"}C and Table [S6](#jah34248-sup-0007){ref-type="supplementary-material"}, see [Methods](#jah34248-sec-0009){ref-type="sec"}). To sum up, all these analyses and results support our TF‐target prediction.

To study TFs with potentially major roles in cardiac‐looping stage cardiomyocyte development, we then focused on TFs that are likely "key drivers," central nodes in a co‐expression network,[30](#jah34248-bib-0030){ref-type="ref"}, [51](#jah34248-bib-0051){ref-type="ref"}, [52](#jah34248-bib-0052){ref-type="ref"}, [53](#jah34248-bib-0053){ref-type="ref"}, [54](#jah34248-bib-0054){ref-type="ref"} and studied what functional pathways they may regulate. Specifically, we selected TFs that were hub genes and actively expressed in individual modules, resulting in 123 TFs (Figure [5](#jah34248-fig-0005){ref-type="fig"}D and Table [S6](#jah34248-sup-0007){ref-type="supplementary-material"}, see [Methods](#jah34248-sec-0009){ref-type="sec"}).

Function Analysis of Well‐Known Transcription Factors Across Cardiac Looping Stages {#jah34248-sec-0030}
-----------------------------------------------------------------------------------

From the 123 TFs, we started with 64 that were previously associated with cardiac phenotypes (referred to as "cardiac TFs," see [Methods](#jah34248-sec-0009){ref-type="sec"}), and asked in which pathways their targets were involved. Since we have already determined pathways, function terms, and heart phenotype‐associated gene sets enriched in each module, we only analyzed the enrichments of a TF\'s targets in these pathways or terms. The analysis identified key drivers by "TF‐driver scores," which tested the association between a TF\'s targets and an enriched pathway or term in a gene module (see [Methods](#jah34248-sec-0009){ref-type="sec"}). As an example, shown in Figure [6](#jah34248-fig-0006){ref-type="fig"}A, TGFβ signaling pathway was enriched in module 4 (Table [S3](#jah34248-sup-0004){ref-type="supplementary-material"}), containing 17 module‐4 genes. Among them, 12 genes were predicted targets of *Id3* and 7 for *Pitx2*, while both *Id3* and *Pitx2* were in this signaling, with TF‐driver score 1.28 and 2.84, respectively. This result suggested that these 2 TFs could be key drivers of this pathway (driver score \>1, see [Methods](#jah34248-sec-0009){ref-type="sec"}), and that *Id3* was likely more important than *Pitx2* to the TGFβ signaling because the former putatively regulated more targets in this pathway, consistent with a previous report that *Id3* was directly activated by BMPs in TGFβ signaling.[64](#jah34248-bib-0064){ref-type="ref"} Extending this TF driver analysis to all the 64 cardiac TFs, we found that ≈80% (n=51) of cardiac TFs were likely key regulators of the signaling pathways enriched in our 5 selected modules, with most cardiac TFs controlling multiple pathways (Figure [6](#jah34248-fig-0006){ref-type="fig"}B, Figures [S4](#jah34248-sup-0008){ref-type="supplementary-material"} and [S5](#jah34248-sup-0006){ref-type="supplementary-material"} and Table [S7](#jah34248-sup-0008){ref-type="supplementary-material"}), such as the well‐studied Gata family, T‐boxes TFs, *Gli3*,*Hey1/2*,*Id1/3*,*Klf6*,*Loxl2*,*Mecom*,*Mef2c*, and *Nr2f2*. On the other hand, ranking the pathways by the number of TF regulators, we found that regulations of the pathways in cardiomyocyte differentiation appeared extremely complex; the top‐ranked pathways, such as extracellular matrix organization, elastic fiber formation, TGFβ signaling, Hippo signaling, axon guidance, and Anaplastic lymphoma kinase (*ALK*) in cardiac myocytes, were predicted to be regulated by \>30 cardiac TFs simultaneously.

![Function and phenotype analysis of cardiac and noncardiac TF targets. **A**, A network showing genes in the transforming growth factor β signaling. In left panel, 17 genes of module 4 were in this pathway, with overrepresentation *P*=1.91e‐09. Node and edge connections in right panel represent adjacencies between a TF and its targets, 12 genes targeted by Id3 and 7 genes for Pitx2. **B**, The number of enriched pathways (*y*‐axis) under the regulations of cardiac, literature‐based cardiac, and noncardiac TFs. **C**, Predicted regulations of cardiac, literature‐based cardiac, and noncardiac TFs in 20 representative heart terms enriched in the selected weighted gene co‐expression network analysis modules. The colors in the heat‐map show the TF‐driver scores in functional terms, representing the regulatory effects of individual TFs on the terms. **D**, Predicted functional roles of literature‐based cardiac and noncardiac TFs in different heart phenotype‐ or disease‐associated gene sets, with the colors for TF‐driver scores. TF indicates transcription factor.](JAH3-8-e012941-g006){#jah34248-fig-0006}

We also extended this analysis to heart phenotype‐ or disease‐associated gene sets. The results suggested that ≈85% (n=54) of cardiac TFs were involved in the regulation of gene sets implicated in multiple heart abnormality or diseases (Table [S7](#jah34248-sup-0008){ref-type="supplementary-material"}), concordant with these TF being defined as "cardiac TFs." Interestingly, the cardiomyopathy‐associated genes were overrepresented in modules 4, 5, and 7 (Table [S3](#jah34248-sup-0004){ref-type="supplementary-material"}), and mainly regulated by *Gli3*,*Klf6*,*Loxl2*,*Hopx*,*Hey2*,*Irx4*, and *Myocd*. In summary, our analysis, in an unsupervised manner, revealed the potentially functional roles of the spatiotemporally expressed cardiac TFs in differentiating cardiomyocytes at critical cardiac‐looping stages.

Analysis of Targets for Less‐Studied TFs in Heart Looping {#jah34248-sec-0031}
---------------------------------------------------------

We next studied the 59 less‐studied TFs (ie, associations with abnormal heart phenotypes have not been clearly established), as analyses of their targeted pathways could provide new insights to their potential functions. Compared with the above results for cardiac TFs, the targets of these less‐studied TFs, such as *Cux1*,*Etv5*,*Id2*,*Irf5*,*Klf4*,*Nfil3*,*Myrf*, and *Skil*, were significantly enriched in many of the same heart developmental terms or processes, supported by similarly high TF‐driver scores (Figure [6](#jah34248-fig-0006){ref-type="fig"}C and Figure [S5](#jah34248-sup-0006){ref-type="supplementary-material"}). Furthermore, our analysis showed that 45 of the 59 TFs were likely to regulate multiple functional pathways that were enriched in the selected gene modules (Figure [6](#jah34248-fig-0006){ref-type="fig"}B, Figure [S4](#jah34248-sup-0008){ref-type="supplementary-material"} and Table [S7](#jah34248-sup-0008){ref-type="supplementary-material"}), indicating their important functional roles. Interestingly, even though the mouse phenotype databases did not associate these TFs with an abnormal phenotype or disease, 21 of the 45 TFs have been reported to perform important functions in heart development: *Hes1*,*Hbp1*,*Skil*,*Irf5*,*Id2*,*Cux1*,*Myrf*,*Kdm5b*,*Grhl1*,*Arhgap35*,*Gatad2b*,*Arid5b*,*Mga*,*Peg3*,*Nfil3*,*Nr2f1*,*Ptrf*,*Camta1*,*Etv1*,*Id4*, and *Nfib*.[67](#jah34248-bib-0067){ref-type="ref"}, [68](#jah34248-bib-0068){ref-type="ref"}, [69](#jah34248-bib-0069){ref-type="ref"}, [70](#jah34248-bib-0070){ref-type="ref"}, [71](#jah34248-bib-0071){ref-type="ref"}, [72](#jah34248-bib-0072){ref-type="ref"}, [73](#jah34248-bib-0073){ref-type="ref"}, [74](#jah34248-bib-0074){ref-type="ref"}, [75](#jah34248-bib-0075){ref-type="ref"}, [76](#jah34248-bib-0076){ref-type="ref"}, [77](#jah34248-bib-0077){ref-type="ref"}, [78](#jah34248-bib-0078){ref-type="ref"}, [79](#jah34248-bib-0079){ref-type="ref"}, [80](#jah34248-bib-0080){ref-type="ref"}, [81](#jah34248-bib-0081){ref-type="ref"}, [82](#jah34248-bib-0082){ref-type="ref"}, [83](#jah34248-bib-0083){ref-type="ref"}, [84](#jah34248-bib-0084){ref-type="ref"}, [85](#jah34248-bib-0085){ref-type="ref"}, [86](#jah34248-bib-0086){ref-type="ref"}, [87](#jah34248-bib-0087){ref-type="ref"}, [88](#jah34248-bib-0088){ref-type="ref"}, [89](#jah34248-bib-0089){ref-type="ref"} As such, we named these TFs as "literature‐based cardiac TFs," to distinguish them from the other "noncardiac TFs" that do not have known evidence for a cardiac function (Table [S6](#jah34248-sup-0007){ref-type="supplementary-material"}). These findings support the biological relevance of our TF‐target prediction, and strongly indicate that the set of noncardiac TFs (n=24) also have high possibilities to regulate critical pathways in embryonic heart development.

Performing enrichment analysis of TFs' targets for the heart phenotype‐ or disease‐associated gene sets enriched in the 5 spatiotemporal modules, we found that the targets of the 21 literature‐based cardiac or the 24 noncardiac TFs were significantly overrepresented in multiple gene sets, such as abnormal cardiac OFT development, abnormal cardiovascular development, abnormal heart ventricle morphology, and abnormal cardiac muscle contractility (Figure [6](#jah34248-fig-0006){ref-type="fig"}D and Figures [S6](#jah34248-sup-0008){ref-type="supplementary-material"} through [S8](#jah34248-sup-0008){ref-type="supplementary-material"}). Notably, \>60 phenotype‐ and disease‐associated gene sets were found to be under the regulations of *Hes1*,*Skil*,*Myrf*,*Etv5*,*Cux1*,*Irf5*, and *Id2*. Most of them, except *Etv5*, have been reported to play a functional role in heart development, suggesting the potential heart genotype--phenotype associations of these TFs.

To confirm the high expression of the OFT‐AVC TFs, we selected 10 less‐studied TFs with the most predicted targets for quantitative polymerase chain reaction analysis. The results showed that almost all of these 10 TFs had significantly higher expressions at OFT‐AVC than ventricles at E10.5, with some also exhibiting higher expression in E9.5 OFT (Figure [7](#jah34248-fig-0007){ref-type="fig"}). Further analysis found that the more specific expression patterns they had, the more heart‐phenotype gene sets these TFs are involved in, with Spearman correlation \>0.7 and *P*\<0.05 at both E9.5 and 10.5 stages (Table [S7](#jah34248-sup-0008){ref-type="supplementary-material"}).

![Quantitative polymerase chain reaction analysis of 10 TFs highly expressed in OFT‐AVC. The bar‐plots show expression fold‐changes (using Gapdh as reference). The statistical significances from comparisons of OFT‐AVC to ventricle at E9.5 and E10.5 separately are indicated by "\*," "\*\*," and "\*\*\*" for *P*\<0.05, 0.005, and 0.0005, respectively. OFT‐AVC indicates outflow tract--atrioventricular canal; TF, transcription factor.](JAH3-8-e012941-g007){#jah34248-fig-0007}

Expression Changes and Functional Roles of TFs in Subgroups of Atrial or Ventricular Cardiomyocytes {#jah34248-sec-0032}
---------------------------------------------------------------------------------------------------

The above analyses considered cardiomyocytes from the same spatial or temporal origin as a "homogeneous" group, but cardiomyocytes in the same group actually showed subtle transcriptional heterogeneity, because cardiomyocytes from the same anatomical location could be a mixture of cells at multiple developmental states. Therefore, we constructed putative developmental trajectories based on top variable genes (see [Methods](#jah34248-sec-0009){ref-type="sec"}) in order to study potential cell state transitions of cardiomyocyte development at atrium, ventricle, or OFT (E9.5 OFT, E10.5 distal OFT and proximal OFT) (Figure [8](#jah34248-fig-0008){ref-type="fig"}A and [8](#jah34248-fig-0008){ref-type="fig"}B, Figure [S9](#jah34248-sup-0008){ref-type="supplementary-material"}). The analysis revealed 3 distinct subgroups ("A", "B," and "C") in each of the trajectories, largely reflecting the temporal and spatial relationship of cardiomyocytes at those locations (Figure [S10](#jah34248-sup-0008){ref-type="supplementary-material"}).

![Differentially expressed genes and TFs in atrial or ventricular cardiomyocytes. **A**, A trajectory of atrial cardiomyocytes, indicating that the atrial cardiomyocytes consisted of 3 major subgroups (**A** through **C**). **B**, The trajectory of ventricular cardiomyocytes. **C** and **D**, Enriched gene sets for the DE genes among the 3 subgroups of atrial (**C**) and ventricular (**D**) cardiomyocytes. Here, DE genes from each of the pairwise comparisons were used for GSEA. The upregulated and downregulated genes are in red and blue nodes, respectively, while the edges of nodes represent the overlapping genes in 2 pathways. **E**, Module enrichments of atrial and ventricular DE genes. The enrichment significance of atrial or ventricular DE genes were represented by the red and blue lines, respectively, in left panel. The right panel shows the top 5 enriched pathways of atrial or ventricular DE genes that were also identified in module 5. **F**, Spatiotemporally DE TFs at atria and ventricles. **G**, The enriched motifs for atrial or ventricular DE TFs in (**F**). DE indicates differentially expressed; ECM, extracellular matrix; GSEA, gene set enrichment analysis; TCA, tricarboxylic acid cycle; TFs, transcription factors.](JAH3-8-e012941-g008){#jah34248-fig-0008}

Gene set enrichment analysis indicated that DE genes from pairwise comparisons of the 3 atrial subgroups were enriched for developmental pathways, such as cell cycle, mRNA processing, protein metabolism, extracellular matrix organization, citric acid cycle, and gluconeogenesis (Figure [8](#jah34248-fig-0008){ref-type="fig"}C and Table [S8](#jah34248-sup-0008){ref-type="supplementary-material"}). In comparison, the enrichment of ventricular DE genes among the 3 subgroups was mainly related to myogenesis, oxidative phosphorylation, angiogenesis, epithelial mesenchymal transition, apical junction, and Heme metabolism pathways (Figure [8](#jah34248-fig-0008){ref-type="fig"}D and Table [S8](#jah34248-sup-0008){ref-type="supplementary-material"}). Interestingly, only a small number of DE genes (\<60) were found among the subgroups of OFT cardiomyocytes, even though cardiomyocytes at this anatomical location were from 2 embryonic heart stages (E9.5 and E10.5). Mapping the DE genes to the above module genes showed that atrial DE genes were significantly enriched in modules 4, 5, and 9, while ventricular DE genes were enriched in modules 5 and 10 (Figure [8](#jah34248-fig-0008){ref-type="fig"}E). Pathway analysis of the overlapped DE genes suggested that both atrial and ventricular DE genes were dramatically overrepresented in module 5 and enriched in pathways related to muscle system process and muscle contraction (Figure [8](#jah34248-fig-0008){ref-type="fig"}E), indicating our trajectories could represent developmental states of cardiomyocytes at different anatomical heart regions.

To further support the importance of TFs in cardiomyocyte development, we examined TFs that were differentially expressed in atrial or ventricular subgroups, and contained in the 5 gene modules. This resulted in 20 DE TFs in the atrial and 10 in the ventricular subgroups (Figure [8](#jah34248-fig-0008){ref-type="fig"}F and Figure [S11](#jah34248-sup-0008){ref-type="supplementary-material"}). Motif analyses showed that the regulatory regions of these atrial DE genes were enriched for 5 TF motifs, *Foxp1* (q‐value 3.61e‐59), *Gli3* (q‐value 3.07e‐04), *Htf4* (q‐value 4.81e‐03), *Irf5* (q‐value 2.71e‐45), and *Tbx3* (q‐value 2.12e‐05) (Figure [8](#jah34248-fig-0008){ref-type="fig"}G). For the ventricular DE genes, *Gli3* motif was found (q‐value 3.41e‐04) (Figure [8](#jah34248-fig-0008){ref-type="fig"}G). The findings strongly supported the regulations of cardiomyocytes differentiation by these TFs that are expressed in a highly spatiotemporal manner.

Discussion {#jah34248-sec-0033}
==========

Our analysis showed that across heart looping stages many signaling and pathways involved in cardiomyocyte differentiation were enriched in the OFT/AVC module (module 4) and they were predicted to be highly regulated by 66 TFs, and more so than genes in the other modules (Figure [9](#jah34248-fig-0009){ref-type="fig"} and Figure [S12](#jah34248-sup-0008){ref-type="supplementary-material"}). In addition, we found that the proportion of TFs in this module was much higher than those of other modules (Figure [S2](#jah34248-sup-0008){ref-type="supplementary-material"}C). Integrating the results of function analysis of "cardiac," "literature‐based cardiac," and "noncardiac" TFs, our study strongly suggests that the genetic program in differentiating cardiomyocytes at OFT/AVC is not only regulated by well‐studied cardiac TFs, such as *Tbx2/3*, but also under the complex regulation of other 64 TFs (Figure [9](#jah34248-fig-0009){ref-type="fig"} and Figure [S12](#jah34248-sup-0008){ref-type="supplementary-material"}), such as *Gli3*,*Mecom*,*Loxl2*, and *Meis2*, including additional TFs whose cardiac functions are yet to be addressed. The high expression of the 10 noncardiac TFs in OFT/AVC was confirmed by quantitative polymerase chain reaction analysis (Figure [7](#jah34248-fig-0007){ref-type="fig"}). Interestingly, we also found a significant correlation between the expression patterns of the noncardiac TFs and the number of heart phenotypes they involved, with greater specific spatial expression correlated with more phenotypes. Considering all the results, we hypothesize that OFT/AVC formation and remodeling is likely the most tightly regulated embryonic heart developmental process. As such, mutations in the genes, especially TFs, important for OFT/AVC development, are likely to be the high‐risk factors for congenital heart defects. In fact, we analyzed 2 sets of manually curated CHD‐associated genes and found that they were significantly enriched in the OFT‐AVC module, with the odds ratios of 2.39 (*P*=0.001) and 2.35 (*P*=0.0003) for the 186 CHD genes in the article by Sifrim et al[90](#jah34248-bib-0090){ref-type="ref"} and the 253 CHD genes in the article by Jin et al,[91](#jah34248-bib-0091){ref-type="ref"} respectively. We also analyzed the genes with significantly higher expression in ECs and MCs of OFT‐AVC than the ECs/MCs of other locations. The results indicated that only the group of genes with higher expression in OFT‐AVC ECs was significantly enriched for the 253 CHD genes curated by Jin et al, suggesting cell‐type specificity of our finding.

![Summary of TFs and their regulatory functions in the spatiotemporal modules. The functional roles of the candidate TFs: cardiac, literature‐based cardiac, and noncardiac, in the 5 selected modules. Each bar‐plot panel of individual modules shows the number of the enriched functional pathways and heart phenotype‐ or disease‐associated gene sets under the regulations of the designated TFs. AVC indicates atrioventricular canal; OFTs, outflow tracts; TFs, transcription factors.](JAH3-8-e012941-g009){#jah34248-fig-0009}

It is worth noting that among the less‐studied TFs, *Etv5* and *Rbpms* are especially strong candidates for future studies. First of all, our analysis showed that *Etv5* and *Rbpms* were associated with hundreds of gene sets for various cardiac GO terms or heart phenotypes (Figure [6](#jah34248-fig-0006){ref-type="fig"}C and [6](#jah34248-fig-0006){ref-type="fig"}D, Table [S7](#jah34248-sup-0008){ref-type="supplementary-material"}). Then, our quantitative polymerase chain reaction results confirmed the high expression of *Etv5* and *Rbpms* in OFT‐AVC at E9.5 and E10.5. Furthermore, these 2 TFs have been implicated in development or diseases. Rbpms*,* as a coactivator for the enhancement of TGFB1/Smad‐mediated transactivation, has been shown to play important roles in transcriptional regulation of human retinas,[92](#jah34248-bib-0092){ref-type="ref"} while *Etv5* was demonstrated to enhance angiogenesis in colorectal cancer.[93](#jah34248-bib-0093){ref-type="ref"} More interestingly, a recent study suggested that *Etv5* is a candidate gene‐regulatory‐network driver in mouse embryonic stem cells,[94](#jah34248-bib-0094){ref-type="ref"} consistent with our finding. Lastly, *Etv1* and *Etv2* play key roles in regulating cardiomyocyte[95](#jah34248-bib-0095){ref-type="ref"} or vascular endothelial cell development.[96](#jah34248-bib-0096){ref-type="ref"} As a member of the same ETS family, *Etv5* may work with *Etv1/2* cooperatively or independently during heart development, an interesting area to explore in the future.

Although our study has analyzed more than 1000 cardiac cardiomyocytes from multiple developmental stages and anatomical locations, the number of total cells is relatively small, considering that new scRNA‐seq technology allows expression profiling of tens of thousands or even up to millions of cells.[97](#jah34248-bib-0097){ref-type="ref"} The inclusion of more cells from more time points can certainly improve our results, especially in terms of finding key TFs regulating cell fate commitment and lineage specification. In theory, with all cardiac cells from the same heart being sampled simultaneously, one can also study the TF‐regulatory networks and signaling cross‐talks among different cardiac cell types, an important matter not addressed in the current study. Finally, it will be necessary to validate our TF‐target predictions using scRNA‐seq data from wild‐type hearts and mutant hearts with the expression of selected TFs compromised, such as previous studies of *Nkx2‐5* function.[12](#jah34248-bib-0012){ref-type="ref"}, [14](#jah34248-bib-0014){ref-type="ref"} Nevertheless, the current study has identified key TFs, including not fully characterized ones, that can play important regulatory roles in embryonic heart development.
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